Edition:
United Kingdom

People: Cytokinetics Inc (CYTK.OQ)

CYTK.OQ on NASDAQ Stock Exchange Global Select Market

8.08USD
18 Apr 2019
Change (% chg)

$0.13 (+1.64%)
Prev Close
$7.95
Open
$7.95
Day's High
$8.22
Day's Low
$7.91
Volume
120,946
Avg. Vol
146,125
52-wk High
$10.42
52-wk Low
$5.76

Roddy, Peter 

Mr. Peter S. Roddy is no longer Senior Vice President, Chief Accounting Officer of the Company, effective May 31, 2019. Mr. Roddy, served as Chief Financial Officer of Pain Therapeutics, Inc, a biopharmaceutical company, from 2002 to 2017 and as Corporate Secretary since 2016. From 1990 to 2002, Mr. Roddy held a variety of senior management positions at COR Therapeutics, Inc., a biopharmaceutical company, including Senior Vice President, Finance and Chief Financial Officer between 2000 and 2002. Mr. Roddy served as a member of the board of directors of Vermilion, Inc. from 2010 to 2016. Mr. Roddy received his B.S. in Business Administration from the University of California, Berkeley.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leonard Patrick Gage

291,926

Robert Blum

2,867,840

Ching Jaw

1,099,890

Fady Malik

1,219,940

Peter Roddy

--

David Cragg

388,209
As Of  31 Dec 2017